catalyst calendar
/
← Catalyst calendar

GMAB biotech catalysts & pipeline

GENMAB A · Data as of 2026-10-27

Upcoming catalysts

petosemtamab (GEN1158) — Topline data

2026

Phase 3 program in 1L HNSCC is ongoing, with topline data anticipated later this year
Source filing

petosemtamab (GEN1158) — Interim data

2026

Merus is currently running two Phase 3 trials in first- and second/third line head and neck cancer, with topline interim readout of one or both trials anticipated in 2026.
Source filing

Explore the free biotech catalyst calendar